The market expects CBOE Global (CBOE - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on July 31, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis holding company for the Chicago Board Options Exchange is expected to post quarterly earnings of $3.41 per share in its upcoming report, which represents a year-over-year change of +38.6%.
Revenues are expected to be $708.54 million, up 20.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.9% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for CBOE?For CBOE, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.83%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that CBOE will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that CBOE would post earnings of $3.37 per share when it actually produced earnings of $3.70, delivering a surprise of +9.79%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
CBOE appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAnother stock from the Zacks Securities and Exchanges industry, IntercontinentalExchange (ICE - Free Report) , is soon expected to post earnings of $1.84 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of +1.7%. Revenues for the quarter are expected to be $2.63 billion, up 3.3% from the year-ago quarter.
The consensus EPS estimate for ICE has been revised 2% lower over the last 30 days to the current level. However, an equal Most Accurate Estimate has resulted in an Earnings ESP of 0.00%.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that ICE will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
SummarySeagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions.On balance, the Fund's artificial intelligence positioning was a net positive contributor to relative performance during the quarter.We added the Humana position on the view that earnings are at a cyclical trough, with MA margins currently depressed, in some cases negative, as elevated medical cost trends have outpaced premium growth across the industry.Intuit was sold following a disappointing growth outlook within its TurboTax segment, where our expectations had been high. Alistair Berg/DigitalVision via Getty Images
The following segment was excerpted from the Nomura Core Equity Fund Q2 2026 Commentary.
Within the Fund For 2Q26, Nomura Core Equity Fund Institutional Class (ICIEX) shares outperformed the Fund's benchmark, the S&P 500
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: CBOE Global (CBOE - Free Report) Based in Chicago, IL, and founded in 1973, Cboe Global Markets, Inc. (effective Oct 17, 2017, CBOE Holdings, Inc. came to be known as Cboe Global Markets, Inc.) is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading.
CBOE is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Finance stock. CBOE has a Momentum Style Score of B, and shares are up 9.8% over the past four weeks.
Nine analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.47 to $13.56 per share. CBOE also boasts an average earnings surprise of +5.4%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CBOE should be on investors' short list.
Key Takeaways CBOE leads on valuation, price gains, growth estimates and analyst sentiment.Recurring revenues and global diversification support CBOE's long-term growth.Nasdaq benefits from non-trading growth, technology expansion and strategic acquisitions. Rising market volatility, pro-growth U.S. policies under President Donald Trump, wider digital-asset adoption, exchanges’ continued diversification beyond traditional trading and increasing retail investor participation are set to shape the industry’s outlook. Against this backdrop, let’s assess which company offers stronger long-term growth prospects — Cboe Global Markets (CBOE - Free Report) or Nasdaq (NDAQ - Free Report) .
Cboe Global Markets holds a dominant position in the U.S. listed options market through its ownership of multiple options exchanges, consistently maintaining the industry's leading market share.
On the other hand, Nasdaq is a leading provider of trading, clearing, marketplace technology, regulatory, securities listing, information and public and private company services.
The Case for CBOECboe Global has developed a well-diversified business through acquisitions and international expansion. Its operations span European equities and derivatives, foreign exchange venues and clearing infrastructure, reducing dependence on any single asset class or geography. Recurring revenues from proprietary market data, index licensing and technology solutions provide stability during periods of softer trading activity, supported by attractive margins and high customer switching costs.
Strong volumes across index options, European equities and foreign exchange continue to support transaction-fee growth, while the Data Vantage segment is expanding recurring revenues. Reflecting this momentum, management raised its 2026 organic net revenue growth outlook to the low-double-digit to mid-teens range and increased its Data Vantage growth target to the low double digits.
Strategic acquisitions and investments are further expanding CBOE’s global reach, product offerings and capital markets infrastructure. The company is also pursuing opportunities in digital assets, carbon markets and next-generation trading technologies while launching innovative derivatives products to address evolving customer needs.
Meanwhile, management is streamlining the portfolio and improving efficiency. The planned divestitures of its Canada and Australia exchanges are expected to lower adjusted operating expenses in 2026.
Cboe Global’s disciplined capital allocation, strong balance sheet and robust free cash flow support growth investments and shareholder returns. The company has raised its dividend for 15 consecutive years and retains $569.4 million under its share-repurchase authorization, highlighting its commitment to returning capital to shareholders.
The Case for NDAQNasdaq operates a diversified business model extending well beyond its traditional exchange operations. Its Market Services segment, covering equities, options and derivatives, benefits from higher trading volumes and market volatility. Meanwhile, Market Technology is expanding annual recurring revenues through subscription-based products and long-term contracts. Cross-selling complementary solutions and integrating acquisitions are also strengthening customer retention and improving revenue visibility.
Organic growth is supported by Nasdaq’s expanding non-trading businesses, including Trading Services and Marketplace Technology, Data and Listing Services, Index, Workflow & Insights and Anti-Financial Crime solutions. These recurring revenue streams have increased the stability and resilience of its overall business mix.
Targeted acquisitions have strengthened Nasdaq’s competitive position by facilitating entry into Canadian equities, broadening its technology capabilities and enhancing market-surveillance offerings. The company is also using advanced technologies and artificial intelligence to modernize market infrastructure and develop innovative solutions for clients.
Nasdaq’s solid balance sheet and steady operating cash flows provide flexibility for shareholder returns and growth investments. Management plans to raise the dividend payout ratio to 35%-38% by 2027 and resume share repurchases to offset dilution related to the Adenza acquisition. Its capital-allocation priorities remain focused on reducing leverage, funding organic growth, pursuing strategic acquisitions, increasing dividends and executing buybacks.
Estimates for CBOE and NDAQ The Zacks Consensus Estimate for CBOE’s 2026 and 2027 revenues implies a 15% and 2.9% year-over-year increase, respectively. EPS estimates for 2026 and 2027 imply a 27.1% and 5.5% year-over-year increase, respectively. EPS estimates for 2026 and 2027 have moved up 1.5% and 1.6%, respectively, in the past 30 days.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for NDAQ’s 2026 and 2027 revenues implies a 10.1% and 7.7% year-over-year increase, respectively. EPS estimates for 2026 and 2027 indicate a 12.6% and 13.4% year-over-year increase, respectively. EPS estimates for 2026 and 2027 have moved up 1% and 2.1%, respectively, in the past 30 days.
Image Source: Zacks Investment Research
Price Performance of CBOE and NDAQCBOE shares have gained 10.7% year to date, while NDAQ shares have lost 3% in the same time.
Image Source: Zacks Investment Research
Are CBOE and NDAQ Shares Expensive?CBOE is trading at a forward 12-month price-to-earnings multiple of 20.1, lower than its median of 27.1 over the past five years. NDAQ’s forward 12-month price-to-earnings multiple sits at 22.71, slightly higher than its median of 22.19 over the past five years.
Image Source: Zacks Investment Research
ConclusionA diversified business mix with recurring revenues, accelerated growth banking on recurring non-transaction revenues, use of technology and prudent buyouts poise CBOE well for growth.
Nasdaq is set to grow on impressive organic growth, an increasing on-trading revenue base and strategic buyouts to capitalize on market opportunities. Nasdaq’s focus on Market Technology and Information Services businesses helps explore vast opportunities through its developmental strategies.
Price appreciation, valuation, growth estimate and analyst sentiment give CBOE an edge over NDAQ. CBOE carries a Zacks Rank #2 (Buy) and has a VGM Score of A. NDAQ carries a Zacks Rank #3 (Hold) and has a VGM Score of C. Thus, CBOE is better placed than NDAQ. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.
However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
CBOE Global (CBOE - Free Report) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
While there are numerous reasons why the stock of this holding company for the Chicago Board Options Exchange is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for CBOE is 15.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 27% this year, crushing the industry average, which calls for EPS growth of 10.9%.
Impressive Asset Utilization RatioAsset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.
Right now, CBOE has an S/TA ratio of 0.5, which means that the company gets $0.5 in sales for each dollar in assets. Comparing this to the industry average of 0.26, it can be said that the company is more efficient.
While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And CBOE looks attractive from a sales growth perspective as well. The company's sales are expected to grow 15% this year versus the industry average of 8.6%.
Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for CBOE. The Zacks Consensus Estimate for the current year has surged 1.6% over the past month.
Bottom LineWhile the overall earnings estimate revisions have made CBOE a Zacks Rank #2 stock, it has earned itself a Growth Score of A based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that CBOE is a potential outperformer and a solid choice for growth investors.
CBOE Global (CBOE - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for CBOE is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
For CBOE, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for CBOEThis holding company for the Chicago Board Options Exchange is expected to earn $13.56 per share for the fiscal year ending December 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for CBOE. Over the past three months, the Zacks Consensus Estimate for the company has increased 10.2%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of CBOE to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Subscribe to CNBC PROSubscribe to Investing ClubLicensing & ReprintsCNBC CouncilsJoin the CNBC PanelDigital ProductsNews ReleasesClosed CaptioningCorrectionsAbout CNBCInternshipsSite MapCareersHelpContactNews TipsGot a confidential news tip? We want to hear from you.
Get In TouchCNBC NewslettersSign up for free newsletters and get more CNBC delivered to your inbox
Sign Up NowGet this delivered to your inbox, and more info about our products and services.
Options and derivatives marketplace Cboe Global Markets (CBOE +3.19%) plans to launch new extended trading hours for select multi-exchange mega-cap stock options.
The extended hours will see the market open for options trading for these select stocks at 7:30 a.m. ET, two hours earlier than the major indexes open for trading. It will stay open until 4:15 p.m. ET, 15 minutes past the rest of the markets. This is for Monday through Friday only.
The 20 or so select stocks are all mega-caps, including all the Magnificent Seven stocks -- Nvidia, Microsoft, Apple, Alphabet, Amazon, Meta, and Tesla. It also includes big names like Broadcom, Palantir, and Advanced Micro Devices.
This is a huge development for Cboe and the markets in general. Now, for the first time, investors will be able to trade stock options for the Magnificent Seven and other market movers two hours before the market opens. That is beneficial for Cboe. Here's why.
Image source: Getty Images.
Cboe thrives on volatility Cboe generates most of its revenue from fees tied to trading on its index. So, the more volatility there is, and the higher the Cboe Volatility Index (VIX) goes, the more revenue Cboe typically generates. So with trading hours extended, it would lead to additional trading and revenue.
In the first quarter, the VIXEQ, Cboe's Constituent Volatility Index, skyrocketed. The VIXEQ measures the volatility of single stocks as opposed to the whole market. The VIXEQ is currently at 50, the highest its been sinced the tariff spike in April 2025 and one of the highest levels in the past five years.
But more importantly, the spread between the VIX and the VIXEQ is at historically wide levels as the VIX is at a pretty normal level -- 15. This means that single stocks are highly volatile, but that voilàtility is masked by a seemingly calm overall VIX.
It is no coincidence that Cboe had a record Q1, with revenue up 29% and earnings up 54% year over year. Options revenue increased 33%, due to a 10% increase in options average daily volume. Transaction and clearing fees for options were up 34%. Equity revenue also set a record, up 18% year over year, with transaction and clearing fees rising 40%.
Cboe stock spiked to an all-time high of $366 per share on May 13, and at that time it was up 46% year to date. It has since come crashing back down on perhaps several factors. There may have been profit-taking, particualrly after the company announced layoffs and volatility appeared to have subsided. Now, Cboe stock is trading at $265 per share, up about 5% YTD.
Cboe Predicts Cboe is also rolling out a new prediction markets product, in conjunction with Charles Schwab, called Cboe Predicts.
It will allow users to trade on predictions about financial markets. The prediction market product and extended trading hours should help Cboe boost revenue, which could help support revenue when markets are less volatile than they were in Q1.
The VIX has settled down and is back in a more normal range but the VIXEQ is extremely high. With the VIXEQ high, large-cap stocks still overvalued, and geopolitical conflicts ongoing, Cboe stock should be one to keep on your radar.
Cboe stock is trading at a more reasonable level at 22 times earnings. The stock has a median price target of $325 per share, which would represent a 21% increase in price.
Cboe stock might be worth buying at this valuation, because if the market gets wild again, you know youʻll have a stock that thrives on volatility.
Dave Kovaleski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Apple, Broadcom, Meta Platforms, Microsoft, Nvidia, Palantir Technologies, and Tesla. The Motley Fool recommends Cboe Global Markets. The Motley Fool has a disclosure policy.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: CBOE Global (CBOE - Free Report) Based in Chicago, IL, and founded in 1973, Cboe Global Markets, Inc. (effective Oct 17, 2017, CBOE Holdings, Inc. came to be known as Cboe Global Markets, Inc.) is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading.
CBOE is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
Additionally, the company could be a top pick for growth investors. CBOE has a Growth Style Score of A, forecasting year-over-year earnings growth of 26.4% for the current fiscal year.
Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.34 to $13.49 per share. CBOE boasts an average earnings surprise of +5.4%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CBOE should be on investors' short list.
The logo of SK Hynix at a SK Hynix booth before a public briefing on the development vision for advanced industry in South Korea's southwestern region, in Gwangju, South Korea, June 30, 2026.... Purchase Licensing Rights, opens new tab Read more
CompaniesJuly 10 (Reuters) - Derivatives exchange Cboe Global Markets (CBOE.Z), opens new tab expects to list options on SK Hynix's (000660.KS), opens new tab U.S.-listed shares two business days after the stock's trading debut, a source familiar with the matter told Reuters on Friday.
The South Korean chipmaker, which raised $26.5 billion in share sale, is set to make its Wall Street entry later in the day. Analysts say it will be a crucial test of investor faith in the AI trade after a recent pullback in semiconductor stocks.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Options tied to the Nasdaq listing will trade according to existing regulatory rules and the Options Listing Procedures Plan framework, the source said on condition of anonymity as the information is confidential.
SK Hynix, which is valued at about $1.03 trillion based on its South Korea-listed shares, did not immediately respond to a Reuters request for comment.
Options trading allows market participants to hedge risk or bet on future share-price moves, typically increasing liquidity and price discovery in a stock.
Investors have poured money into companies tied to the AI boom, betting that years of heavy spending on chips and computing infrastructure will drive steady demand for companies such as SK Hynix.
More recently, however, concerns about lofty valuations have triggered bouts of volatility across the sector.
"In a shallow correction, SK Hynix holds up better because its supply is the most locked and the most strategic. In a deep AI winter, Micron's diversification and U.S. positioning make it the relative safe haven," said Daniel Newman, CEO of tech research firm Futurum Group.
Heavy retail participation could also make the stock's options market active, as traders seek leveraged exposure to AI-related names, a dynamic that can amplify gains as well as losses.
Elon Musk-led SpaceX's (SPCX.O), opens new tab options launched last month have attracted record trading volumes.
Reporting by Manya Saini and Pritam Biswas in Bengaluru; Editing by Arun Koyyur
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Manya covers the most influential U.S. financial institutions, from Wall Street’s largest banks and card networks to leading asset managers and fintech companies. She also reports on late-stage venture capital fundraises, initial public offerings on U.S. exchanges and regulatory developments shaping the cryptocurrency industry. Her work appears across the finance, markets, business and future of money sections of the Reuters website. She holds a bachelor’s degree in political science from the University of Delhi and a master’s in journalism from the Symbiosis Institute of Media and Communication.
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CBOE Global (CBOE - Free Report) , which belongs to the Zacks Securities and Exchanges industry.
When looking at the last two reports, this holding company for the Chicago Board Options Exchange has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 7.11%, on average, in the last two quarters.
For the last reported quarter, CBOE came out with earnings of $3.7 per share versus the Zacks Consensus Estimate of $3.37 per share, representing a surprise of 9.79%. For the previous quarter, the company was expected to post earnings of $2.93 per share and it actually produced earnings of $3.06 per share, delivering a surprise of 4.44%.
Price and EPS Surprise
For CBOE, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
CBOE currently has an Earnings ESP of +2.69%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 31, 2026.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
, /PRNewswire/ -- Langar Investment Management LLC, the adviser to the Langar Global HealthTech ETF (NYSE Arca: LGHT), today announced the transfer of the primary listing of LGHT from NYSE Arca to the Cboe BZX Exchange on or about June 29, 2026.
Current shareholders of LGHT are not required to take any action, nor is the transfer expected to have any effect on the trading of the Fund's shares. The Fund's investment objective, strategies, and investment management team will remain unchanged.
For more information on the Langar Global HealthTech ETF, please visit langarfunds.com.
About Langar Investment Management
Langar Investment Management is the investment management subsidiary of Langar Technology, Inc. and the adviser to the Langar Global HealthTech ETF (LGHT) — the first ever pure-play healthtech ETF. LGHT seeks long-term growth of capital and offers investors targeted exposure to companies at the intersection of healthcare and technology, including digital health, medical devices, health data infrastructure, and AI-driven diagnostics. For more information, visit langarfunds.com.
Important Disclosures
Nothing contained in this material should be construed as an offer to sell nor a solicitation of an offer to buy shares of the Langar Global HealthTech ETF. This material must be preceded or accompanied by a current prospectus. Investors should read the prospectus carefully before investing.
Investing involves risk, including possible loss of principal. The Fund's shares are bought and sold at market price, not at net asset value ("NAV") per share. The shares may trade at a premium or discount to NAV. Brokerage commissions will reduce returns.
The Langar Global HealthTech ETF is distributed by Paralel Distributors LLC. Paralel Distributors LLC is not affiliated with Langar Investment Management or Langar Technology, Inc.
Index Dow Jones -0,34 % na 52874,68 b. S&P 500 -0,31 % na 7514,09 b. Nasdaq Composite -0,71 % na 25936,59 b.
US indexy se pohybují v červeném pásmu, část ztrát se jim ale již podařilo smazat. Nejméně klesá index S&P 500, kde je nejslabším sektorem průmysl. GE Vernova klesá o 8,8 %, Deere & Co ztrácí 6,1 % a Caterpillar, který je i nejslabší emisí indexu Dow Jones odepisuje 5,5 %.
Dalším klesajícím sektorem je sektor informačních technologií. Akcie společností zaměřených na umělou inteligenci se ocitly pod tlakem v důsledku poklesu akcií společnosti Samsung o 7 % na domácí korejské burze. Samsung ráno oznámil předběžné výsledky za druhé čtvrtletí, v nichž očekává tržby ve výši přibližně USD 112,7 mld. a provozní zisk USD 59 mld. Oba tyto údaje výrazně překonaly konsensus, což však nestačilo k pozitivní reakci trhu. Dobrou náladu nepřinesla ani zpráva o čínské společnosti DeepSeek, která začala vyvíjet vlastní čip pro umělou inteligenci. Intel odepisuje 9,5 %, Micron Technology a AMD odepisují přibližně 6 %.
Fiserv roste o 1,9 % po informacích o možném budoucím prodeji její platební sítě STAR konsorciu bank, jako je JPMorgan Chase, anebo Bank of America. Získání vlastní sítě na zpracování plateb by bankám snížilo náklady a podpořilo například věrnostní programy pro debetní karty.
SpaceX (- 4,9 %) se dnes stal součástí indexu Nasdaq 100. Po připojení do indexu se objevilo hned několik investičních doporučení. Např. JP Morgan má cílovou cenu USD 225, Goldman Sachs akcie doporučuje k nákupu s cílovou cenou USD 205 a UBS má cílovou cenu USD 210.
Hormuzský průliv byl dnes místem útoku Iránu na tanker na zkapalněný zemní plyn. V reakci mírně stoupá cena ropy. Futures kontrakty na WTI rostou o 2,8 % na úroveň pod USD 70,5 a po sérií poklesů stoupají i Exxon Mobil (2,2 %) a Chevron (1,5 %).
Index S&P 500 -0,31 % na 7514,09 b. Nejsilnější sektory S&P Změna Nejslabší sektory S&P Změna Reality +1,7 % Průmysl -2,3 % Zdravotní péče +1,5 % Informační technologie -1,1 % Energie +1,3 % Základní materiály -1 % Nejsilnější akcie S&P Změna Nejslabší akcie S&P Změna Cognizant Technology Solutions Corp (CTSH) +6,3 % Teradyne (TER) -10 % Gartner (IT) +5,8 % Generac Holdings (GNRC) -10 % Cboe Global Markets (CBOE) +5,4 % Intel Corp (INTC) -9,5 % GoDaddy (GDDY) +5,3 % GE Vernova (GEV) -9,1 % ServiceNow (NOW) +5,0 % Sandisk Corp (SNDK) -8,9 %
Marek Kameništiak
Fio banka, a.s.
Prohlášení
Key Takeaways CBOE's revenues grew about 25% in two years on strength across options, equities, futures and data.Cboe Global's options franchise is driven by SPX and VIX demand for hedging, income and volatility needs.CBOE raised its organic net revenue growth outlook to low double-digit to mid-teens growth. Cboe Global Markets' (CBOE - Free Report) revenue growth is being driven by structural market trends, product innovation and an increasingly diversified business model. The company’s revenues have risen by approximately 25% over the past two years, reflecting strength across multiple business lines. Unlike traditional exchanges that rely primarily on cash equity trading, Cboe generates revenues from options, equities, futures, foreign exchange, digital assets and market data.
Its options franchise remains the largest growth engine. Strong institutional demand for SPX and VIX index options for portfolio hedging, income generation and volatility management continues to drive transaction and clearing revenues, while periods of elevated market volatility provide an additional boost to trading activity.
Cboe Global is also expanding its base of recurring, non-transaction revenues through market data, connectivity and access services. These high-margin businesses benefit from growing demand from quantitative firms, algorithmic traders and institutional investors for proprietary market data, making revenues less dependent on trading volumes.
International expansion further strengthens the outlook. Acquisitions across Europe, Canada, Australia and Japan have broadened CBOE’s customer base and created cross-selling opportunities, while investments in foreign exchange and digital asset infrastructure position the company to capture emerging institutional demand.
Although trading activity is inherently cyclical, Cboe Global's increasingly diversified revenue mix provides greater resilience. Growth in recurring revenues, its international operations and continued product innovation reduce reliance on any single business segment. Reflecting these favorable trends, management has raised its outlook and now expects organic net revenue growth in the low double-digit to mid-teens range, compared with its previous guidance of mid-single-digit growth.
What About CBOE’s Peers?Nasdaq Inc. (NDAQ - Free Report) has strengthened its revenue growth profile by expanding beyond exchange trading into financial technology, market data, indexes, and anti-financial crime solutions, building a stable base of recurring subscription revenues. This diversification enables Nasdaq to generate consistent top-line growth despite fluctuations in trading activity and benefit from global demand for its technology platforms.
Intercontinental Exchange (ICE - Free Report) has similarly diversified through energy and interest-rate derivatives, mortgage technology and data services. Intercontinental Exchange is steadily increasing recurring revenues from its technology businesses, enhancing revenue visibility. Thus, Intercontinental Exchange remains well-positioned for sustainable long-term revenue growth.
CBOE’s Price PerformanceShares of Cboe Global have lost 0.8% year to date, outperforming the industry, but underperforming sector and S&P 500.
Image Source: Zacks Investment Research
CBOE’s Expensive ValuationCBOE is currently trading at a forward price-to-earnings multiple of 18.05, lower than the industry average of 18.16.
Image Source: Zacks Investment Research
Estimate Movement for CBOEThe Zacks Consensus Estimate for CBOE’s second and third-quarter 2026 earnings per share (EPS) witnessed no movement in the last seven days. The consensus estimate for 2026 and 2027 earnings has moved 1 cent north each, respectively, in the last seven days.
Key Takeaways Cboe Global stock is down 0.8% year to date, outperforming the industry but lagging the sector.Management raised its 2026 organic total net revenue outlook to low double-digit to mid-teens growth.Cboe Global has raised its dividend for 15 straight years and has $569.4M left for buybacks. Shares of Cboe Global Markets (CBOE - Free Report) have lost 0.8% year to date, outperforming the industry. It, however, lagged the sector as well as the Zacks S&P 500 composite.
Cboe Global Markets is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. As global capital markets continue to become increasingly electronic and data-driven, CBOE is well-positioned to capitalize on secular trends in trading volumes, demand for market data, and the expansion of index-based investing.
CBOE vs Industry, Sector, S&P 500 YTD
Image Source: Zacks Investment Research
Shares of Nasdaq Inc (NDAQ - Free Report) have lost 13% year to date, while those of Intercontinental Exchange (ICE - Free Report) have lost 19.8% in the same time frame.
CBOE Shares Are AffordableThe stock is overvalued compared with its industry. It is currently trading at a forward price-to-earnings multiple of 18.05, lower than the industry average of 18.16 and the median of 21.71 over five years.
Image Source: Zacks Investment Research
CBOE is relatively cheap compared to Nasdaq but expensive compared to Intercontinental Exchange.
The Case for CBOE StockCboe Global Markets holds a dominant position in the U.S. listed options market through its ownership of multiple options exchanges, consistently maintaining the industry's leading market share.
The company has also built a diversified business through acquisitions and international expansion. Its portfolio now includes European equities and derivatives exchanges, foreign exchange trading venues and clearing infrastructure, reducing reliance on any single asset class or region. In addition, recurring revenues from proprietary market data, index licensing and technology solutions provide stability during periods of weaker trading activity. These businesses generate attractive margins and benefit from high customer switching costs.
Strong trading activity across index options, European equities and foreign exchange continues to drive transaction fee growth, while its Data Vantage business is expanding high-quality recurring revenues. Reflecting this momentum, management raised its 2026 organic total net revenue growth outlook to the low double-digit to mid-teens range and increased its Data Vantage organic growth target to low double digits.
Cboe Global is further strengthening its long-term growth profile through strategic acquisitions and investments that expand its global footprint, product portfolio and capital markets infrastructure. The company is also investing in digital assets, carbon markets and next-generation trading technologies while introducing innovative derivatives products to meet evolving client demand.
At the same time, management is optimizing its portfolio and cost structure. The company has agreed to divest its Canada and Australia exchanges and expects these actions to reduce adjusted operating expenses in 2026, improving overall efficiency.
The company's disciplined capital allocation supports strategic investments while maintaining a strong balance sheet and robust free cash flow generation. Cboe Global has increased its dividend for 15 consecutive years and has $569.4 million remaining under its existing share repurchase authorization, underscoring its commitment to returning capital to shareholders.
Cboe Global’s Growth ProjectionsThe Zacks Consensus Estimate for 2026 revenues indicates a 13.1% year-over-year increase, while that for earnings suggests a 25.2% year-over-year decline. The consensus estimate for 2027 revenues indicates a 2.8% year-over-year increase, while that for earnings suggests an increase of 5.6% year over year.
The expected long-term earnings growth rate is pegged at 16.8%, better than the industry average of 12.2%. It has a Growth Score of A.
Optimist Analyst Sentiment on CBOEThe consensus estimate for 2026 and 2027 earnings has moved 1.2% and 1.4% north, respectively, in the past 30 days, reflecting analysts' optimism.
Image Source: Zacks Investment Research
The consensus estimate for 2026 earnings of Nasdaq and Intercontinental Exchange has moved north in the past 30 days.
Parting Thoughts on CBOE SharesA diversified business mix with recurring revenues, accelerated growth banking on recurring non-transaction revenues, use of technology and prudent buyouts poise CBOE well for growth. Its VGM Score of B instills confidence.
Given affordable valuation, solid growth projections and optimistic analyst sentiment, it’s time to add this Zacks Rank #1 (Strong Buy) stock to one’s portfolio. You can see the complete list of today’s Zacks #1 Rank stocks here.
Corgi lists 14 single-stock 2x Daily ETFs plus the Corgi Quantum Computing 2x Daily ETF on June 30, each at a 0.45% expense ratio and the lowest net expense ratio of any U.S.-listed 2x daily long ETF tracking the same underlying,* and nine July Series Structured Buffer ETFs on July 2, offering built-in downside buffers at a gross expense ratio of 0.40% and net expense ratio of 0.30%.**
, /PRNewswire/ -- Corgi, an AI fintech startup, announced the launch and listing of 24 ETFs on Cboe BZX Exchange across two product lines this week: 15 leveraged 2x Daily ETFs on June 30 and nine July Series Structured Buffer ETFs on July 2. The launches continue the firm's staged rollout across leveraged and defined-outcome strategies.
Leveraged 2x Daily ETFs
The 15 leveraged funds comprise 14 single-stock 2x Daily ETFs plus the Corgi Quantum Computing 2x Daily ETF, each at a 0.45% expense ratio and the lowest net expense ratio of any U.S.-listed 2x daily long ETF tracking the same underlying.* Each single-stock fund is named in the form "Corgi [ticker] 2x Daily ETF" and seeks 2x the daily performance of the referenced stock. The funds are the Corgi AAPL 2x Daily ETF (Cboe BZX: IOSX), referencing Apple; and the corresponding funds referencing ASML (ASMZ), Broadcom (AVGC), Galaxy Digital (GLX), IonQ (IONC), Oracle (ORAC), Rocket Lab (RKX), Super Micro Computer (SMCC), Archer Aviation (ACHX), Arm Holdings (ARMA), Bloom Energy (BEC), Cipher Mining (CIFC), Eos Energy (EO), and GameStop (GMEC).
The Corgi Quantum Computing 2x Daily ETF (Cboe BZX: XQTM) seeks 2x the daily performance of the Corgi Quantum Computing ETF (CQTM), Corgi's actively managed quantum computing fund, for a single day. XQTM carries a 0.45% expense ratio, the lowest net expense ratio of any U.S.-listed 2x daily long quantum-computing-themed ETF.*
July Series Structured Buffer ETFs
The nine buffer funds use FLEX Options (Flexible Exchange Options) to seek exposure to the price return of a reference ETF up to a cap, while seeking to buffer against a defined level of downside losses over an annual outcome period running from July 1, 2026 to June 30, 2027. All nine carry a gross expense ratio of 0.40% and a net expense ratio of 0.30%,** among the lowest net expense ratios in the structured buffer ETF category, based on publicly available data from ETF Central as of June 19, 2026.
U.S. Equities (SPDR S&P 500 ETF Trust): Corgi U.S. Equities 10% Structured Buffer ETF – July Series (Cboe BZX: JULC), 15% (CJUL), 30% (CTJL), and 100% (HJLY).
Growth & Technology (Invesco QQQ Trust, tracking the Nasdaq-100 Index): Corgi Growth & Technology 10% Structured Buffer ETF – July Series (Cboe BZX: QJL) and 15% (QQJL).
U.S. Small-Cap (iShares Russell 2000 ETF): Corgi U.S. Small-Cap 15% Structured Buffer ETF – July Series (Cboe BZX: SCJL).
International Developed (iShares MSCI EAFE ETF): Corgi International Developed Equities 15% Structured Buffer ETF – July Series (Cboe BZX: IDJL).
Buffer levels range from 10% to 100%. CTJL is designed to participate in the price return of the SPDR S&P 500 ETF Trust (SPY) up to a cap, with a 30% downside buffer that absorbs SPY losses between -5% and -35% over each annual outcome period. HJLY is designed to participate in the price return of SPY up to a cap, while targeting a 100% buffer against all SPY losses over each annual outcome period. With the July Series, Corgi's structured buffer lineup spans 27 funds across three monthly series, with an average gross expense ratio of 0.40% and net expense ratio of 0.30%.**
"We launched each leveraged fund with the lowest net expense ratio among U.S.-listed 2x daily long ETFs on its underlying, based on publicly available data as of June 19, 2026, and added a new July Series of Structured Buffer ETFs for investors seeking downside buffers," said Nicolas Laqua, CEO. "We believe investors value greater choice and competitive pricing, and these launches reflect our commitment to delivering both."
All 24 funds are listed on Cboe BZX Exchange and can be bought and sold throughout the trading day through broker-dealers and other financial intermediaries. Investors may pay brokerage commissions and may also incur platform, custodial, advisory, and other fees or expenses charged by their financial intermediary. Leveraged ETFs involve significant risk and are designed primarily for sophisticated investors managing positions daily.
About Corgi
Founded in 2025, Corgi is an AI Financial Infrastructure Company creating innovative products in insurance and finance. We're building the foundation for a new generation of financial services, with AI and technology at the core from day one. To learn more about Corgi, follow us on LinkedIn, on X, or at www.corgifunds.com.
Important Information
Investors should consider the investment objectives, risks, charges and expenses carefully before investing. The prospectus contains this and other information about the Funds and should be read carefully before investing. A copy of the prospectus is available at www.corgifunds.com.
Investing involves risk, including possible loss of principal. There is no guarantee that any Fund will achieve its investment objective.
Leveraged Funds. Each leveraged Fund seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of its underlying, for a single day, and does not seek that objective over periods longer than one trading day. Due to the effects of compounding, returns over periods longer than one day may differ significantly from 2x the underlying's performance, particularly during volatile markets. The use of leverage magnifies both gains and losses and may result in significant losses. The leveraged Funds use derivatives, including swap agreements, which add counterparty, liquidity, valuation, and tracking-error risk. Each leveraged Fund is non-diversified and concentrates its exposure in a single underlying security or reference ETF, making it more volatile than a diversified fund, and is intended for sophisticated investors who manage positions actively, not for buy-and-hold investors. The Corgi Quantum Computing 2x Daily ETF seeks 2x the daily performance of the Corgi Quantum Computing ETF, an actively managed, non-diversified fund concentrated in quantum computing and quantum-ready security companies.
Buffer Funds. Each buffer Fund seeks the price return (excluding dividends) of its reference ETF up to a predetermined cap, while seeking to buffer a defined level of reference ETF losses over an approximately one-year outcome period; the buffer is before fees and expenses. There is no assurance the buffer will be achieved. The buffer is not principal protection, and a shareholder may lose some or all of their investment. The intended buffered outcome is generally sought only for shareholders who hold for the full outcome period; investors who buy after the FLEX Options are established, or sell before they expire, may experience different results. Certain Funds employ a "deep buffer" in which shareholders bear the first portion of losses before the buffer applies, and losses beyond the buffer range. Gains are limited by the Cap, which is established at the start of each outcome period based on prevailing market conditions and may rise or fall from one period to the next. The Funds use FLEX Options issued and guaranteed for settlement by The Options Clearing Corporation ("OCC") and are subject to OCC counterparty risk and the risk that FLEX Options trade in less liquid markets.
The companies referenced by the single-stock leveraged Funds, and the reference ETFs used by the buffer Funds, are not affiliated with Corgi Strategies, LLC, Corgi, or Paralel Distributors, LLC, and have not sponsored, endorsed, sold, or promoted the Funds and make no representation regarding the advisability of investing in the Funds.
The Funds are newly organized and have limited or no operating history. ETF shares trade at market price (not NAV), are not individually redeemable, and may trade at a premium or discount to NAV. Brokerage commissions will reduce returns.
This release is informational only and not an offer or solicitation; offers are made only by prospectus.
*Expense ratio comparisons for the leveraged Funds are among U.S.-listed 2x daily long ETFs on the same underlying, based on net expense ratios from ETF Central as of June 19, 2026. For the Corgi Quantum Computing 2x Daily ETF, the comparison is among U.S.-listed 2x daily long quantum-computing-themed ETFs. Expense ratios are subject to change and new funds may launch, which could affect these comparisons.
**The net expense ratio for the buffer Funds reflects a contractual fee waiver by Corgi Strategies, LLC (the "Adviser"), which has agreed to waive a portion of its management fee equal to 0.10% of each Fund's average daily net assets. This agreement has no termination date and may not be terminated without the approval of the Board of Trustees, upon not less than thirty (30) days' prior written notice to the Adviser; provided that the Board may not terminate the agreement with respect to any Fund prior to the one-year anniversary of the effective date of the agreement with respect to such Fund. Amounts waived are not subject to recoupment by the Adviser. The gross expense ratio for each buffer Fund is 0.40%.
Paralel Distributors, LLC (FINRA/SIPC) is the distributor. Corgi Strategies, LLC is the adviser. Paralel is unaffiliated with Corgi Strategies, LLC and Corgi. COR108
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 1:
Alliance Laundry Holdings Inc. (ALH - Free Report) : This commercial laundry systems company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
Alliance Laundry has a PEG ratio of 1.23 compared with 1.40 for the industry. The company possesses a Growth Score of A.
Cboe Global Markets, Inc. (CBOE - Free Report) : This derivatives and securities exchange network carriesa Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days.
Cboe Global Markets has a PEG ratio of 1.03 compared with 1.65 for the industry. The company possesses a Growth Score of A.
Delek US Holdings, Inc. (DK - Free Report) : This integrated downstream energy company carriesa Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days.
Centene has a PEG ratio of 0.33 compared with 0.49 for the industry. The company possesses a Growth Score of A.
See the full list of top-ranked stocks here.
Learn more about the Growth score and how it is calculated here.
AI-Driven Cardiovascular Diagnostics Company Brings Early Detection Technology to Capital Markets
TORONTO--(BUSINESS WIRE)--Cboe Canada Inc. (“Cboe Canada”) today announced the listing of GuideAI Health Corp. (“GuideAI”), an artificial intelligence healthcare company focused on improving the detection, management, and outcomes of vascular disease. The company's common shares are now available for trading on Cboe Canada, under the symbol GDAI.
GuideAI is developing an AI platform designed to transform complex medical imaging and clinical data into actionable diagnostic insights. Its mission is to make advanced cardiovascular diagnostic intelligence accessible to a broader range of healthcare providers beyond major academic and research centers.
"We are pleased to welcome GuideAI to Cboe Canada," said CEO, Joacim Wiklander. "Their work at the intersection of artificial intelligence and cardiovascular health represents exactly the kind of innovative, high-growth company that Canadian public markets should be supporting. We look forward to their continued growth as a publicly listed company."
The listing on Cboe Canada gives GuideAI access to an internationally recognized exchange with deep expertise in emerging sectors and a strong commitment to capital formation for innovative companies.
"Going public marks an important milestone for GuideAI as we scale our platform and broaden access to life-changing diagnostic technology," said Raj Shah, CEO of GuideAI Health Corp. "We are excited to join the Cboe Canada community and look forward to delivering on our mission for patients, clinicians, and shareholders alike."
Investors can trade shares of GDAI through their usual investment channels, including discount brokerages and full-service dealers. To explore all listed securities on Cboe Canada, click here.
Cboe Canada continues to attract innovative companies and asset managers by offering a streamlined listing process, competitive fee structure, and access to a diverse and engaged investor base. The exchange is home to leading Canadian and international growth companies, ETFs from Canada’s most reputable ETF issuers, and an expansive suite of Canadian Depositary Receipts (CDRs). Cboe Canada consistently facilitates close to 15% of all trading volume in Canadian listed securities.
About Cboe Canada
Cboe Canada is Canada’s senior stock exchange providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists companies and investment products seeking a robust and internationally recognized platform that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data.
Connect with Cboe Canada: Website | LinkedIn | X
About GuideAI Health Corp.
GuideAI Health Corp. is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease. By surfacing disease earlier, GuideAI aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 29:
Celestica Inc. (CLS - Free Report) : This supply chain solutions provider carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.
Celestica has a PEG ratio of 0.73 compared with 0.96 for the industry. The company possesses a Growth Score of B.
Cboe Global Markets, Inc. (CBOE - Free Report) : This derivatives and securities exchange network carriesa Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
Cboe Global Markets has a PEG ratio of 1.08 compared with 1.65 for the industry. The company possesses a Growth Score of A.
Centene Corporation (CNC - Free Report) : This managed care company carriesa Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.
Centene has a PEG ratio of 0.51 compared with 1.13 for the industry. The company possesses a Growth Score of B.
See the full list of top-ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.
By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.
However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.
CBOE Global (CBOE - Free Report) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
While there are numerous reasons why the stock of this holding company for the Chicago Board Options Exchange is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for CBOE is 15.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 25.1% this year, crushing the industry average, which calls for EPS growth of 11.2%.
Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.
Right now, CBOE has an S/TA ratio of 0.5, which means that the company gets $0.5 in sales for each dollar in assets. Comparing this to the industry average of 0.26, it can be said that the company is more efficient.
In addition to efficiency in generating sales, sales growth plays an important role. And CBOE is well positioned from a sales growth perspective too. The company's sales are expected to grow 13.1% this year versus the industry average of 9.4%.
Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for CBOE. The Zacks Consensus Estimate for the current year has surged 0.3% over the past month.
Bottom LineCBOE has not only earned a Growth Score of A based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #1 because of the positive earnings estimate revisions.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that CBOE is a potential outperformer and a solid choice for growth investors.
Craig Donohue, Cboe Global Markets CEO, joins 'The Exchange' to discuss the importance of the Cboe, the derivatives portion of equity markets and much more.
CBOE Global (CBOE - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.
RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.
Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.
So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.
However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.
Why CBOE Could Bounce Back Before LongThe RSI reading of 29.13 for CBOE is an indication that the heavy selling could be in the process of exhausting itself, so the stock could bounce back in a quest for reaching the old equilibrium of supply and demand.
The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for CBOE has increased 0.3%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
Moreover, CBOE currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Key Takeaways CBOE Global Markets and Tutor Perini passed a low-leverage stock screen.CBOE launched Cboe Predicts, while Tutor Perini secured a $114 million Ole Miss project contract.Casey's unveiled a three-year plan targeting 400 added stores through acquisitions and development. Wall Street finished June 24, 2026, on a mixed note, as investors actively rotated out of high-flying technology stocks to find support in cyclical and consumer discretionary sectors. This rotation caused the tech-heavy Nasdaq and the benchmark S&P 500 to pull back, while the broad-based Dow Jones Industrial Average managed to inch higher.
While concerns surrounding overvalued tech companies triggered the localized sell-off, energy investors found unexpected relief in a steady decline in oil prices. Crude benchmarks plummeted to their lowest levels since February-end, before the United States and Israel launched joint airstrikes against Iran.
However, this newfound stability in energy prices is unlikely to persist for long, given the structural geopolitical tensions still simmering across the globe.
Against this volatile landscape, turning to financially resilient companies, particularly those with low leverage, is a necessity right now.
These fiscally conservative companies are better positioned to navigate interest rate fluctuations and geopolitical uncertainty. By providing a stable foundation in a shifting market, they can serve as a strategic hedge against a potential energy-driven economic slowdown.
We recommend low-leverage stocks, such as Ternium (TX - Free Report) , CBOE Global Markets (CBOE - Free Report) , Tutor Perini (TPC - Free Report) , Sunstone Hotel Investors (SHO - Free Report) and Casey’s General Stores (CASY - Free Report) .
Before selecting low-leverage stocks, it is important to understand what leverage is and how investing in low-leverage companies can benefit investors.
What’s the Significance of Low-Leverage Stocks?In finance, leverage refers to the use of borrowed capital to support business operations and drive expansion. Companies typically raise such funds through debt financing, although equity financing remains an alternative. However, firms often prefer debt due to its relatively lower cost and easier availability compared to issuing equity.
Debt financing comes with inherent risks and is beneficial only when it generates returns that exceed the cost of borrowing. To limit downside risk, investors should be cautious of companies that rely excessively on debt. Prudent investing involves selecting businesses with manageable leverage, as completely debt-free companies are rare.
The equity market can be volatile at times. As an investor, if you want to avoid significant losses, we suggest focusing on stocks with low leverage, which are generally deemed less risky.
To identify such stocks, several leverage ratios have historically been developed to measure the amount of debt a company carries. The debt-to-equity ratio is among the most widely used financial ratios.
Analyzing Debt/EquityDebt-to-Equity Ratio = Total Liabilities/Shareholders’ Equity
This metric is a liquidity ratio that indicates the amount of financial risk a company bears. A lower debt-to-equity ratio suggests improved solvency for a company.
With the second-quarter 2026 earnings season ahead of us, investors should focus on stocks that have demonstrated solid earnings growth in recent periods.
If a stock carries a high debt-to-equity ratio during an economic downturn, its seemingly strong earnings could quickly turn into a nightmare.
The Winning StrategyConsidering the aforementioned factors, it would be prudent to choose stocks with a low debt-to-equity ratio to ensure steady returns.
Yet, an investment strategy based solely on the debt-to-equity ratio might not fetch the desired outcome. To select stocks with the potential to provide steady returns, we have expanded our screening criteria to include additional factors.
Other Parameters:
Debt/Equity Less Than X-Industry Median: Stocks that are less leveraged than their industry peers.
Current Price Greater Than or Equal to 10: The stocks must be trading at $10 or higher.
Average 20-day Volume Greater Than or Equal to 50000: A substantial trading volume ensures that the stock is easily tradable.
Percentage Change in EPS F(0)/F(-1) Greater Than X-Industry Median: Earnings growth adds to optimism, leading to a stock’s price appreciation.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy), offer the best upside potential.
Estimated One-Year EPS Growth F (1)/F(0) Greater Than 5: This shows earnings growth expectations.
Zacks Rank #1 or 2: Irrespective of market conditions, stocks with a Zacks Rank #1 or 2 have a proven history of success.
Excluding stocks that have a negative or a zero debt-to-equity ratio, we present our five picks out of the 12 that made it through the screen.
Ternium: It is the leading producer of flat and long steel products of Latin America and consolidates the operations of the steel companies like Hylsa in Mexico, Siderar in Argentina and Sidor in Venezuela.
On May 5, 2026, the company announced its first-quarter 2026 results. Its earnings per ADS improved a massive 220.6% to $1.09. Ternium invested $406 million in the first quarter, primarily for the expansion of its industrial center in Pesquería, Mexico.
The Zacks Consensus Estimate for TX’s 2026 sales indicates an improvement of 6.1% from the prior-year reported level. The stock boasts a long-term (three-to-five year) earnings growth rate of 52.80%. It currently sports a Zacks Rank #1.
CBOE Global Markets: It is the world's go-to derivatives and exchange network, delivering cutting-edge trading, clearing and investment solutions to people around the world. On June 23, 2026, CBOE announced the launch of the first products in its new prediction markets suite, Cboe Predicts. Cboe Predicts represents the latest expansion of CBOE’s S&P 500 Index (SPX) product suite.
The Zacks Consensus Estimate for CBOE’s 2026 revenues indicates an improvement of 13.1% from the prior-year reported actuals. The stock boasts a long-term earnings growth rate of 16.80%. CBOE currently sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Tutor Perini: It is a diversified general contracting, construction management and design-build services provider to private clients and public agencies worldwide. On June 9, 2026, Tutor Perini announced that its subsidiary, Roy Anderson Corp, has won a contract worth approximately $114 million for the Jones Hall Project at the University of Mississippi (Ole Miss) in Oxford, MS. Per the terms of this project, TPC will construct a new four-story, approximately 110,000-square-foot academic facility that will serve as the home of the nationally recognized Patterson School of Accountancy.
The Zacks Consensus Estimate for TPC’s 2026 revenues indicates an improvement of 12.7% from the prior-year reported number. The Zacks Consensus Estimate for TPC’s 2026 earnings indicates an improvement of 20.8% from the prior-year reported number. It currently holds a Zacks Rank #2.
Sunstone Hotel Investors: It is a lodging real estate company that owns hotels primarily in the upper-upscale and upscale segments, primarily operated under franchises owned nationally-recognized companies, such as Marriott, Hilton, InterContinental and Hyatt.
On June 23, 2026, Sunstone Hotel Investors reported that it has entered into a definitive agreement to sell the 821-room Hyatt Regency San Francisco hotel to funds affiliated with Blackstone Real Estate for a gross sale price of $279 million.
The Zacks Consensus Estimate for SHO’s 2026 revenues indicates an improvement of 4.5% from the prior-year reported actuals. The stock boasts a long-term earnings growth rate of 4.90%. It currently sports a Zacks Rank #1.
Casey’s General Stores: It is a chain of convenience stores that operates across 19 states of the United States. On June 24, 2026, the company unveiled its new three-year strategic plan, which focused on expanding CASY’s food business, growing its store base, and leveraging technology to improve efficiency and execution. In particular, the company plans to add at least 400 stores through a combination of strategic acquisitions and new-store development.
The Zacks Consensus Estimate for CASY’s fiscal 2027 revenues suggests an improvement of 16.2% from the year-ago reported level. The stock boasts a long-term earnings growth rate of 15.80%. It currently sports a Zacks Rank #1.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 23:
Cboe Global Markets, Inc. (CBOE - Free Report) : This derivatives and securities exchange network carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.
Cboe has a PEG ratio of 1.11 compared with 1.60 for the industry. The company possesses a Growth Score of A.
Centene Corporation (CNC - Free Report) : This managed care company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.3% over the last 60 days.
Centene has a PEG ratio of 0.47 compared with 1.06 for the industry. The company possesses a Growth Score of A.
Credo Technology Group Holding Ltd (CRDO - Free Report) : This high-speed connectivity solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.5% over the last 60 days.
Credo Technology has a PEG ratio of 1.16 compared with 1.39 for the industry. The company possesses a Growth Score of B.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Learn more about the Growth score and how it is calculated here.
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.
To view the full publication, “Next-Generation DNA Repair Therapies Open New Frontiers in Oncology,” please visit: https://ibn.fm/LL2Es
Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage Response inhibitors (“DDRi”), which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP inhibitor. DDRi therapies collectively represented an estimated $7-plus billion in global sales in 2025, and the broader oncology, diagnostics and precision medicine markets are projected to climb to roughly $750 billion by 2030.
New inhibitor classes are emerging as the next major wave. Sitting at the forefront of this shift is Onco-Innovations Limited, a Canadian clinical-stage oncology company developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor that targets a DNA repair enzyme involved in multiple DNA repair pathways. As the field races to find the next generation of synthetic lethality assets, Onco-Innovations occupies a unique space as it strengthens its position in the biopharmaceutical and biotechnology sector.
About Onco-Innovations Limited
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco’s mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumors.
For further information, please visit the company’s website at www.OncoInnovations.com.
NOTE TO INVESTORS: The latest news and updates relating to ONNVF are available in the company’s newsroom at https://ibn.fm/ONNVF
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
DISCLAIMER: BioMedWire (BMW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by BMW are solely those of BMW. Readers of this Article and content agree that they cannot and will not seek to hold liable BMW for any investment decisions by their readers or subscribers. BMW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, BMW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
BMW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BMW undertakes no obligation to update such statements.
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
Key Takeaways CBOE grew Q1 net revenue 29% to $728.9M, led by a 32% increase in derivatives revenue.Cboe's SPX options reached record volume, while Data Vantage revenue climbed to $181.3M.CBOE is cutting costs through restructuring and had $569.4M remaining for share repurchases. Cboe Global Markets, Inc. (CBOE - Free Report) shares have lost 28.4% over the past month compared with the industry's decline of 10%.
The stock has been weighed down by concerns over its valuation compression, competitive threats, and selling pressure after a strong rally that reached a 52-week high in May. Investor sentiment has also been affected by market-share erosion and expectations of lower market volatility that could reduce trading activity. However, the solid earnings growth, record trading volumes, a profitable derivatives and market-data business, and prudent capital deployment position the company well for long-term growth.
Shares of some of its peers, including Intercontinental Exchange Inc. (ICE - Free Report) , CME Group Inc. (CME - Free Report) , and Nasdaq, Inc. (NDAQ - Free Report) , have lost 14.1%, 15.8% and 9.2%, respectively, in the past month.
1-Month Price Performance: CBOE, ICE, CME, NDAQ & Industry
Image Source: Zacks Investment Research
CBOE’s Average Target Price Suggests UpsideBased on short-term price targets offered by 14 analysts, the Zacks average price target is $317.50 per share. The average suggests a potential 24% upside from the last closing price.
Image Source: Zacks Investment Research
CBOE ValuationShares of Cboe Global are currently trading at a discount. Its forward price-to-earnings (P/E) ratio is 18.69X, which is below the industry average of 18.72X.
Image Source: Zacks Investment Research
Shares of Intercontinental Exchange are trading at a discount, while CME and Nasdaq are trading above the industry average.
CBOE’s Growth Projection EncouragesThe Zacks Consensus Estimate for Cboe Global’s 2026 earnings per share (EPS) indicates a year-over-year increase of 25%. The consensus estimate for revenues is pegged at $2.75 billion, implying a year-over-year improvement of 13.1%.
The consensus estimate for 2027 EPS and revenues indicates an increase of 5.5% and 2.9%, respectively, from the corresponding 2026 estimates.
Earnings have grown 14.7% in the past five years, better than the industry average of 10.6%. The expected long-term earnings growth rate is 16.8%, %, better than the industry average of 12.2%. It also has a Growth Score of A.
Optimist Analyst Sentiment on CBOE10 analysts covering the stock have raised estimates for 2026 and 2027 over the past 60 days, with no downward revisions. Thus, the Zacks Consensus Estimate for 2026 and 2027 earnings has moved up 8.8% and 9.1%, respectively, over the same period.
CBOE’s Favorable Return on CapitalReturn on equity for the trailing-12 months was 24.9%, which compared favorably with the industry’s average of 16%. This reflects its efficiency in utilizing shareholders’ funds.
Return on invested capital in the trailing-12 months was 14.6%, better than the industry average of 6.7%, reflecting CBOE’s efficiency in utilizing funds to generate income.
What Drives CBOE’s Growth?Cboe Global’s organic strength lies in a diversified business mix that ensures uninterrupted revenue generation and recurring non-transaction revenues. The company is sharpening its focus on core derivatives, data, clearing and off-exchange businesses through portfolio optimization, including the planned sale of its Canada and Australia operations. At the same time, CBOE is investing in high-growth opportunities such as prediction markets, tokenized products and expanded clearing services.
Trading activity across Cboe’s derivatives complex continues to be the primary organic growth engine. Net revenue rose 29% year over year to $728.9 million, with derivatives net revenue up 32% in the first quarter of 2026. Proprietary SPX options set another quarterly record with average daily volume up 34% year over year to 4.9 million contracts, supported by both shorter-dated and longer-dated demand as market conditions shifted. Management raised its 2026 organic total net revenue growth target to low double-digit to mid-teens.
Growing demand for market data, connectivity services and analytics solutions is driving solid growth in the Data Vantage segment. In the first quarter of 2026, Data Vantage revenue increased to $181.3 million from $152.5 million a year ago, supported primarily by new customer additions and increased product adoption. Management lifted its 2026 Data Vantage organic net revenue growth target to low double-digit.
The multi-quarter realignment is now paired with additional actions aimed at reducing complexity and improving execution. Management expects these initiatives to reduce its workforce by approximately 20% and be substantially completed by the end of 2026. Management also lowered 2026 expense guidance and expects meaningful savings from restructuring initiatives.
CBOE’s strategic investments are well supported by solid capital management. The company has been strengthening its balance sheet with a strong cash position supporting continued investment in technology, sales and product initiatives as well as capital returns, while lowering its debt balance. As of March 31, 2026, it had $569.4 million remaining under existing share repurchase authorizations.
ConclusionCboe Global’s growth strategy of expanding its product line across asset classes, broadening geographic reach, diversifying the business mix with recurring revenues, and leveraging technology reflects its operational expertise. A VGM Score of B instils optimism.
Coupled with cheap valuation, optimistic analyst sentiment, favorable ROE and favorable growth estimates, the time appears right for potential investors to bet on this Zacks Rank #1 (Strong Buy) insurer. You can see the complete list of today’s Zacks #1 Rank stocks here.
, /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced the launch of the first products in its new prediction markets suite, Cboe PredictsSM.
The offering includes binary option contracts based on the Mini-S&P 500 Index (XSP), listed under the symbols XSPBW and XSPBX. The contracts are now available on Interactive Brokers and expected to roll out at Charles Schwab in the coming months, with additional retail brokerage platforms expected to offer access over time.
Cboe PredictsSM represents the latest expansion of Cboe's S&P 500 Index (SPX) product suite. XSP allows customers to trade on the performance of the S&P 500 Index (SPX) but is scaled to 1/10th the size of SPX – making it a smaller, more retail-friendly alternative. Traders can express a view on where XSP may close by taking a "yes" position (paying $100 if the index settles at or above a specified level, or $0 otherwise) or a "no" position (paying $100 if it settles below that level, or $0 otherwise).
"Following the success of SPX 0DTE options, we have seen continued customer demand for shorter-dated, outcome-based trading, creating a natural extension for Cboe to introduce XSP binary options," said JJ Kinahan, Head of Retail Expansion and Alternative Investment Products at Cboe. "Cboe's S&P 500 options suite has long provided traders with flexibility to define their outcomes through traditional options strategies. With Cboe Predicts, we are expanding that choice by offering simple 'yes-or-no' payout event contracts, supported by dedicated educational resources designed to help customers participate more confidently and responsibly."
In a future release, Cboe also plans to enable trading of XSP vertical spreads through its proprietary, patent-pending Quoted Spread BookSM (QSBSM) framework. The framework is designed to package widely used options strategies into a simpler, more intuitive format, helping newer traders already comfortable with "yes/no" outcomes build familiarity with more advanced options concepts within defined-risk strategies.
Through access provided by leading retail brokers, Cboe's intermediated model is designed to encompass high standards for customer education, market access and oversight. Additionally, these securities-based products are centrally cleared through the Options Clearing Corporation (OCC), providing enhanced risk management during the settlement process.
"OCC stands ready to bring the same clearing infrastructure and risk management discipline that underpins all of the products we clear to the new binary options," said Mike Hansen, Chief Clearing and Settlement Services Officer at OCC. "Our commitment to operational excellence and financial integrity ensures that participants can engage with confidence, knowing every transaction is supported by sound, well-established clearing and settlement services."
"Investors increasingly seek products that allow them to express a specific view on future events and market outcomes," said Milan Galik, Chief Executive Officer of Interactive Brokers. "Cboe's binary options and Mini-S&P 500 Index contracts provide another way to do that, and we are pleased to make them available to Interactive Brokers clients."
"We support approaches that bring transparency, defined risk, and investor education to financial-related prediction markets," said James Kostulias, Head of Trading Services, Charles Schwab. "We plan to offer clients access to these binary options contracts in the coming months, building on our existing platform and demand from active traders."
"For more than 50 years, Cboe has built and operated some of the world's most established and trusted markets," said Rob Hocking, Global Head of Derivatives at Cboe. "We look forward to bringing our experience, trusted market infrastructure and the deep liquidity of the SPX options ecosystem to prediction markets. Our goal is to help set a higher standard for market integrity, product design and investor protection by offering access through a regulated securities exchange and central clearing through OCC."
Cboe has also introduced educational resources, including a new prediction markets resource hub and courses through The Options Institute, a leader in options education for more than 40 years. These courses guide learners from market basics and decision-making through Cboe's 'yes/no' contracts, then into core options concepts.
Cboe's XSP prediction market contracts are security options and will trade within the same regulatory framework as U.S.-listed options, providing institutional-grade liquidity, transparency, and surveillance, among other benefits.
About Cboe Global Markets
Cboe Global Markets (Cboe: CBOE) is a leading global markets operator with a long history of innovation in equity and index derivatives. Since launching the world's first listed options exchange in 1973, Cboe has pioneered landmark products, including the introduction of S&P 500® index options and the creation of the VIX® Index, the world's leading gauge of market volatility, reshaping how investors manage risk and access opportunity. Today, Cboe operates derivatives, equities, and FX markets, providing trading, clearing, and investment solutions for customers worldwide. To learn more, visit www.cboe.com.
Cboe Media Contacts
Cboe Analyst Contact
Angela Tu
Tim Cave
Kenneth Hill, CFA
+1-646-856-8734
+44 (0) 7593-506-719
+1-312-786-7559
[email protected]
[email protected]
[email protected]
CBOE-C
CBOE-OE
Cboe®, Cboe Global Markets®, and VIX ® are registered trademarks and Cboe PredictsSM, Quoted Spread BookSM, and QSBSM are service marks of Cboe Exchange, Inc., and S&P 500® is a registered trademark of Standard & Poor's Financial Services LLC. All other trademarks and service marks are the property of their respective owners.
Cautionary Statements Regarding Forward-Looking Information
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. You can identify these statements by forward-looking words such as "may," "might," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," and the negative of these terms and other comparable terminology. All statements that reflect our expectations, assumptions or projections about the future other than statements of historical fact are forward-looking statements. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements.
We operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
Some factors that could cause actual results to differ include: the loss of our right to exclusively list and trade certain index options and futures products; economic, political and market conditions; compliance with legal and regulatory obligations; price and new products and services competition and consolidation in our industry; decreases in trading or clearing volumes, market data fees or a shift in the mix of products traded on our exchanges; legislative or regulatory changes or changes in tax regimes; our ability to protect our systems and communication networks from security vulnerabilities and breaches; our ability to attract and retain skilled management and other personnel; increasing competition by foreign and domestic entities; our business and operational dependence on and exposure to risk from third parties; factors that impact the quality and integrity of our and other applicable indices; our ability to manage our global operations, growth, and strategic acquisitions, wind downs, divestitures, or alliances effectively; increases in the cost of the products and services we use; our ability to operate our business without violating the intellectual property rights of others and the costs associated with protecting our intellectual property rights; our ability to minimize the risks, including our credit, liquidity, market, investment, counterparty, and default risks, associated with operating our clearinghouses; our ability to accommodate trading and clearing volume and transaction traffic, including significant increases, without failure or degradation of performance of our systems; misconduct by those who use our markets or our products or for whom we clear transactions; challenges to our use of open source software code; our ability to meet our compliance obligations, including managing our business interests and our regulatory responsibilities; the loss of key customers or a significant reduction in trading or clearing volumes by key customers; damage to our reputation; the ability of our compliance and risk management methods to effectively monitor and manage our risks; restrictions imposed by our debt obligations and our ability to make payments on or refinance our debt obligations; our ability to maintain an investment grade credit rating; impairment of our goodwill, long-lived assets, investments or intangible assets; the accuracy of our estimates and expectations; and litigation risks and other liabilities. More detailed information about factors that may affect our actual results to differ may be found in our filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2025 and other filings made from time to time with the SEC.
We do not undertake, and we expressly disclaim, any duty to update any forward-looking statement whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
SPCX stock is climbing. See the chart and price action here. Gamma Squeeze Ahead? Experts expect high implied volatility from the start. Analysts at SpotGamma point out there is no positioning history, no IV anchor and no established gamma exposure profile — meaning options will price extreme uncertainty from day one.
Wide bid-ask spreads and rich premiums are the baseline expectation.
The structural setup is also notable: SPCX’s tradable float is just 3% to 5% of the company’s valuation, and that thinness matters enormously for options dealers.
If retail call-buying dominates early flow, dealers will likely be short gamma on a stock with almost no liquidity cushion — meaning their hedging activity amplifies price moves rather than dampening them.
The call-buying and dealer hedging could lead to a gamma squeeze — a rapid, often extreme surge in a stock’s price driven by the options market rather than the company’s underlying fundamentals.
It occurs when heavy buying of call options forces market makers to aggressively purchase the underlying stock to hedge their risk.
SpotGamma called the SpaceX setup “one of the highest-gamma-sensitivity environments of the decade.”
Zero Hedge also predicted a possible gamma squeeze that could drive the price to $400 per share.
"SPCX options start trading tomorrow: it could gamma squeeze to 400, surpassing NVDA," Zero Hegde wrote in a post on X.
Demand For SPCX Shares Is Sky-High Compounding the dynamic: an estimated $22 billion to $27 billion in forced mechanical index buying is expected from Nasdaq-100 and Russell trackers in the coming weeks, with SPCX’s Nasdaq-100 fast-entry expected 15 trading days post-IPO.
SpaceX is currently unprofitable, posting a net loss of $4.28 billion in Q1 2026 — making it the only publicly traded company over $1 trillion in market cap that isn’t generating profit. That hasn’t slowed demand.
"It has the TAM of a science fiction novel while the price to earnings-growth ratio of chips is the lowest it's been in the sector's history," Mike Purves, CEO of Tallbacken Capital Advisors, told CNBC.
"But there's a huge bid in upside calls for anything AI-related and that means the price for protection is higher too – I'd suggest SpaceX will be having that dynamic magnified."
Reuters reported that more than 115,000 options contracts on SpaceX were traded in the first ten minutes and 500,000 options contracts changed hands in the first hour, according to Trade Alert data.
The ExchangesFor exchanges, the moment is massive. Cboe and Nasdaq handled nearly 60% of all options volume last year, according to Bloomberg, and will host SPCX options.
Robinhood Markets Inc. (NASDAQ:HOOD), where options trading represents roughly a quarter of total revenue, could stand to benefit significantly.
SPCX Stock Price Activity: SpaceX stock was up 11.44% at $214.53 at the time of publication Tuesday, according to Benzinga Pro.
Photo: Dimitris Barletis / Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: CBOE Global (CBOE - Free Report) Based in Chicago, IL, and founded in 1973, Cboe Global Markets, Inc. (effective Oct 17, 2017, CBOE Holdings, Inc. came to be known as Cboe Global Markets, Inc.) is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading.
CBOE is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of B.
Additionally, the company could be a top pick for growth investors. CBOE has a Growth Style Score of A, forecasting year-over-year earnings growth of 25% for the current fiscal year.
10 analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $1.26 to $13.34 per share. CBOE boasts an average earnings surprise of +5.4%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CBOE should be on investors' short list.
Subscribers to Schaeffer's Weekend Trader options recommendation service received this CBOE commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters. Learn more about why Weekend Trader is one of our most popular options trading services.
Cboe Global Markets Inc (NYSE:CBOE) recently sold off on news that prediction market platform Polymarket is seeking CFTC approval, sparking concerns about increased competition. The sharp pullback dragged shares back toward their March lows, though the stock found support at its 200-day moving average and +10% year-to-date level.
The options landscape remains constructive. Put support has emerged at the 270 strike, where the shares recently bounced, while max pain levels continue to trend higher through the summer months. Meanwhile, CBOE's 50-day buy-to-open put/call ratio sits in the 73rd percentile of readings from the past year, indicating options traders are more bearish than usual. This leaves ample room for pessimism to unwind should the stock resume its longer-term uptrend.
Our recommended call option has a leverage ratio of 6.5 and will double on a 16.7% rise in the underlying equity.
The SEC Moves to End the $25,000 Day Trading Barrier
For years, this rule kept most traders on the sidelines. Now, the door is opening to a whole new wave of active traders.
Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.
CHICAGO, May 11, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, today announced the hiring of Julie Bauer as Senior Vice President, Head of Government Relations, effective May 19, 2026. Ms. Bauer will lead Cboe's global engagement and advocacy efforts with regulators, policymakers, and industry stakeholders, while helping to advance its long-term strategy.
CHICAGO, May 14, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, today announced the preliminary shareholder voting results from its 2026 Annual Meeting held today. All 12 board of director nominees served during the 2025-2026 board term and received a majority of votes cast.
CHICAGO, May 14, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, today announced its Board of Directors has declared a quarterly cash dividend of $0.72 per share of common stock for the second quarter of 2026. The second-quarter 2026 dividend is payable on June 15, 2026, to stockholders of record as of May 29, 2026.
Dow Jones Industrial Average index (DJX) options now have contracts expiring every trading day Exclusively listed on Cboe, DJX options are based on index 1/100th the size of Dow Jones Industrial Average Expansion of expirations reflects growing demand for short-dated index options trading strategies CHICAGO, May 18, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, today announced the expansion of its Dow Jones Industrial Average® index (DJX) options suite with the addition of daily expiring options, effective May 18, 2026. DJX options are exclusively listed and traded on Cboe Options (C1) and Cboe C2 Options (C2) exchanges and provide investors access to one of the oldest and most widely followed equity indices, the Dow Jones Industrial Average (DJIA®), which measures the performance of 30 blue-chip U.S. companies.
Cboe Global drives growth with diversified revenues, global expansion and Data Vantage fee gains, supported by a strong balance sheet and strategic buyouts.
CHICAGO, May 26, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced the planned hiring of Boudewijn Duinstra as Executive Vice President and Chief Risk Officer. Upon joining at a future date, Mr.
Cboe to launch pre- and post-market trading sessions for select equity options, beginning July 13, 2026 Eligible equity options must meet minimum options volume and underlying equity market cap and liquidity thresholds Initiative builds on Cboe's efforts to expand investor access to U.S. markets CHICAGO, May 28, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced the Securities and Exchange Commission (SEC) has approved its filing to begin offering extended trading hours for select multi-listed equity options. Cboe Options Exchange (C1) plans to begin offering the extended trading hours on July 13, 2026, subject to SEC approval of a related rule filing.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
On May 29, 2026, Cboe Global Markets Inc (CBOE) shares fell 3.1% to a current price of $333.56. The stock has experienced a 52-week range between $218.14 and $3
CHICAGO, June 3, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today reported May trading volume statistics across its global business lines. The data sheet "Cboe Global Markets Monthly Volume & RPC/Net Revenue Capture Report" contains an overview of certain May trading statistics and market share by business segment, volume in select index products, and RPC/net capture, which is reported on a one-month lag, across business lines.
CBOE (CBOE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Joshua Brown is still bullish on Shake Shack, while Malcolm Ethridge recommends Morgan Stanley and Jim Lebenthal picks AbbVie Inc. as their final trades.
